Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode Licenses Magnetic Bead Patents to Douglas for Ag-bio Platform

NEW YORK (GenomeWeb News) – Applied BioCode today announced a non-exclusive licensing deal with Douglas Scientific for the development of a high-throughput automation platform for ag-bio applications using Applied BioCode's Barcoded Magnetic Bead technology.

The Santa Fe Springs, Calif.-based company provides Douglas certain patents for its technology, which Douglas will combine with its Array Tape technology to develop a solution "for highly multiplexed assay capability," Applied BioCode said. The instrument system will be able to read an entire 384-well plate and provide up to 9,600 results in less than three minutes, it added.

Financial and other terms were not disclosed.

BMBs are a next-generation digital multiplexing technology that can test up to 4,096 targets from the same sample.

"The combination of Douglas Scientific's Array Tape with our Barcoded Magnetic Beads will provide a powerful nucleic acid testing platform for high volume agriculture companies," Applied BioCode CEO Jerry McLaughlin said in a statement. "We are confident that our license agreement with Douglas Scientific will be a valuable addition to Applied BioCode in the global commercialization of our Barcoded Magnetic Bead technology four future bio-discovery and IVD applications."

Applied BioCode develops highly multiplexed barcoded magnetic beads and analyzer products for molecular diagnostics, bioresearch, and biomarker validation.

Douglas Scientific, based in Alexandria, Minn., is a division of Douglas Machine and develops high-throughput laboratory automation optimized for Array Tape, a flexible microplate replacement "engineered to be a ubiquitous media for high-throughput processing," the company said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.